12. Krumholz A, Wiebe S, Gronseth G, Shinnar S, Levisohn P, Ting T, et al. Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. Nov 20 2007;69(21):1996-2007.
13. American College of Emergency Physicians. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures. Ann Emerg Med. May 2004;43(5):605-25.
14. Olson KR, Kearney TE, Dyer JE, Benowitz NL, Blanc PD. Seizures associated with poisoning and drug overdose. Am J Emerg Med. May 1994;12(3):392-5.
15. Tardy B, Lafond P, Convers P, Page Y, Zeni F, Viallon A, et al. Adult first generalized seizure: etiology, biological tests, EEG, CT scan, in an ED. Am J Emerg Med. Jan 1995;13(1):1-5.
16. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. Aug 18 1993;270(7):854-9.
17. Shearer P, Park D. Seizures and Status Epilepticus: Diagnosis and Management in the Emergency Department. Emergency Medicine Practice. August 2006;8(8).
18. Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. Aug 2010;164(8):747-53.
19. Ratanakorn D, Kaojarern S, Phuapradit P, Mokkhavesa C. Single oral loading dose of phenytoin: a pharmacokinetics study. J Neurol Sci. Mar 20 1997;147(1):89-92.
20. Van Der Meyden CH, Kruger AJ, Müller FO, Rabie W, Schall R. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures. Epilepsia. Jan-Feb 1994;35(1):189-94. [Medline].
21. Venkataraman V, Wheless JW. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res. Jun 1999;35(2):147-53.
22. Purcell TB, McPheeters RA, Feil M, Chavez R. Rapid oral loading of carbamazepine in the emergency department. Ann Emerg Med. Aug 2007;50(2):121-6.
23. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev. Oct 19 2005;CD003723.
24. Gellerman GL, Martinez C. Fatal ventricular fibrillation following intravenous sodium diphenylhydantoin therapy. JAMA. Apr 24 1967;200(4):337-8.
25. Zoneraich S, Zoneraich O, Siegel J. Sudden death following intravenous sodium diphenylhydantoin. Am Heart J. Mar 1976;91(3):375-7. [Medline].
26. Wilder BJ. Use of parenteral antiepileptic drugs and the role for fosphenytoin. Neurology. Jun 1996;46(6 Suppl 1):S1-2.
27. Lin T. Fosphenytoin. Cleveland Clinic Center for Continuing Education. Available at http://www.clevelandclinicmeded.com/medicalpubs/pharmacy/novdec2004/fosphenytoin.htm. Accessed August 7, 2009.
28. Marik PE, Varon J. The management of status epilepticus. Chest. Aug 2004;126(2):582-91.
29. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. Feb 2002;43(2):146-53. [Medline].
30. Powell-Jackson PR, Tredger JM, Williams R. Hepatotoxicity to sodium valproate: a review. Gut. Jun 1984;25(6):673-81.
31. Cannon ML, Glazier SS, Bauman LA. Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion. J Neurosurg. Dec 2001;95(6):1053-6..
32. Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence?. Neurology. Nov 1998;51(5):1256-62..
33. French JA, Pedley TA. Clinical practice. Initial management of epilepsy. N Engl J Med. Jul 10 2008;359(2):166-76..